First Thing, Daily Maverick's flagship newsletter

Join the 230 000 South Africans who read First Thing newsletter.

We write for you

It’s a public service and we refuse to erect a paywall and force you to pay for truth. Instead, we ask (nicely and often) that those of you who can afford to, become a Maverick Insider and help with whatever you can. In order for truth not to become a thing of the past, we need to keep going.

Currently, 18,000 (or less than 0.3%) of our brave and generous readers are members; which says a lot about their characters and commitment to our country. These people are paying for a free service in order to keep it free for everyone.

They are the true South AfriCANs.(Sorry, we couldn’t help ourselves.)

Support Daily Maverick→
Payment options

Pfizer Shot Halts Severe Illness in Israel as Delta Spr...



Pfizer Shot Halts Severe Illness in Israel as Delta Spreads

A tray of syringes containing a dose of the Pfizer-BioNTech Covid-19 vaccine at Kanto Rosai Hospital in Kawasaki, Kanagawa Prefecture, Japan, on Thursday, March 4, 2021. Japanese Prime Minister Yoshihide Suga said the virus emergency in the Tokyo region now set to expire on March 7 may need to be extended for another two weeks, as he seeks to further rein in the pace of infections.
By Bloomberg
05 Jul 2021 0

(Bloomberg) --Pfizer Inc.’s vaccine was less effective at keeping people from getting the coronavirus in Israel in recent weeks, but it continues to provide a strong shield against severe Covid-19, according to government data.

By Alisa Odenheimer and Damian Shepherd
Jul 5, 2021, 9:59 AM – Updated on Jul 5, 2021, 8:21 PM
Word Count: 388
The vaccine protected 64% of people against the illness between June 6 and early July, down from a previous 94%. The drop was observed as the delta variant was spreading in Israel, the Health Ministry said. It also coincided with the lifting of virus restrictions at the start of June.

Despite the indications of increased infections, the data also showed the shot is protecting people from severe illness. Its effectiveness at preventing hospitalization fell to 93%, according to the Health Ministry, compared with at least 97% in an earlier government study.

Delta, which first emerged in India, is spreading around the globe as governments race to inoculate people. The mutation has forced some countries to delay or rethink plans to loosen curbs on businesses, activity and travel.

Pfizer spokeswoman Dervila Keane declined to comment on the data from Israel. She pointed to research showing the vaccine’s continued protection against new mutations — just slightly reduced in some cases. The evidence so far suggests that the vaccine “will continue to protect against these variants,” she said.

From Alpha to Delta, Why Virus Mutations Cause Alarm: QuickTake

Israel had one of the world’s most effective coronavirus inoculation drives. About 57% of the population is now fully vaccinated.

Many new Covid-19 cases are among vaccinated people, according to Ynet news service. Last Friday, 55% of the newly infected had been vaccinated, the website said. As of July 4, there were 35 serious cases of coronavirus out of a population of 9.3 million, compared with 21 on June 19.

The government plans to study vaccinated individuals who contracted the coronavirus, including factors such as age, pre-existing conditions and inoculation dates, in order to evaluate the efficacy of the vaccine and the rate at which it wears off, the prime minister’s office said.

The government is considering reinstating additional restrictions after restoring a mandate to wear masks indoors in public spaces. No decision has been on recommending a third dose of vaccine, the health ministry said.

Pfizer Chief Executive Officer Albert Bourla has said people will likely need a third dose within 12 months of getting fully protected.


Comments - share your knowledge and experience

Please note you must be a Maverick Insider to comment. Sign up here or sign in if you are already an Insider.

Everybody has an opinion but not everyone has the knowledge and the experience to contribute meaningfully to a discussion. That’s what we want from our members. Help us learn with your expertise and insights on articles that we publish. We encourage different, respectful viewpoints to further our understanding of the world. View our comments policy here.

No Comments, yet

Please peer review 3 community comments before your comment can be posted